JAZZ - Jazz Pharmaceuticals PLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JAZZ is currently covered by 14 analysts with an average price target of $268.07. This is a potential upside of $49.23 (9.03%) from yesterday's end of day stock price of $245.87.

Jazz Pharmaceuticals PLC's activity chart (see below) currently has 334 price targets and 258 ratings on display. The stock rating distribution of JAZZ is 97.67% BUY and 2.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.01% with an average time for these price targets to be met of 817.98 days.

Highest price target for JAZZ is $337, Lowest price target is $199, average price target is $268.07.

Most recent stock forecast was given by ASHWANI VERMA from UBS.

Best performing analysts who are covering JAZZ - Jazz Pharmaceuticals PLC:

Ami Fadia Balaji Prasad Oren Livnat Gregory Renza Joon Lee

Currently out of the existing stock ratings of JAZZ, 42 are a BUY (97.67%), 1 are a HOLD (2.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Sep-2026

$337

$91.2 (37.10%)

$307

Buy Since 06-Mar-2025

$322

$76.2 (31.00%)

$283

20 days ago
(25-Aug-2026)

11/14 (78.57%)

$72.71 (29.17%)

668

Buy Since 14-Jul-2025

$300

$54.2 (22.05%)

$210

20 days ago
(25-Aug-2026)

3/4 (75%)

$50.71 (20.34%)

113

Buy Since 01-Mar-2022

$281

$35.2 (14.32%)

$264

20 days ago
(25-Aug-2026)

15/17 (88.24%)

$31.71 (12.72%)

663

Buy Since 01-Jan-2018

$310

$64.2 (26.12%)

$292

20 days ago
(25-Aug-2026)

36/39 (92.31%)

$60.71 (24.35%)

831

Show more analysts

Please expand the browser size to see the chart

What is JAZZ (Jazz Pharmaceuticals PLC) average time for price targets to be met?

On average it took 818 days for the stock forecasts to be reached, with an average price target met ratio of 80.01%.

Which analyst most recently updated their price target on JAZZ (Jazz Pharmaceuticals PLC)?

Ashwani Verma

Which analyst has the most public recommendations on JAZZ (Jazz Pharmaceuticals PLC)?

Ashwani Verma works at UBS and has 25 price targets and 15 ratings on JAZZ

Which analyst is the currently most bullish on JAZZ (Jazz Pharmaceuticals PLC)?

Ashwani Verma with the highest potential upside of $91.2

Which analyst is the currently most reserved on JAZZ (Jazz Pharmaceuticals PLC)?

Charles Duncan with the lowest potential downside of -$105.8

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?